Potential risk of proton pump inhibitors for Parkinson's disease: A nationwide nested case-control study.
Proton pump inhibitor (PPI) use is a potential risk factor for neurodegenerative disease development; however, its role in Parkinson's disease (PD) remains unclear. This study aimed to investigate the association between PPI use and PD risk. A total of 31,326 patients with newly diagnosed PD were ma...
Sparad:
| Huvudupphov: | , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Public Library of Science (PLoS)
2023-01-01
|
| Serie: | PLoS ONE |
| Länkar: | https://doi.org/10.1371/journal.pone.0295981 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|